Under the deal, the two parties will establish scalable processes for manufacturing recombinant adeno-associated viral (rAAV) vector products using current good manufacturing practices (cGMP). The deal will combine
The placebo-controlled, single ascending dose evaluation trial is conducted in Germany and patients from the first cohort have been dosed. The trial, designed to evaluate the safety and
The trial is designed to evaluate the efficacy and safety of revusiran in patients with FAC, which is one of the predominant clinical manifestations of TTR-mediated amyloidosis (ATTR).
The application seeks to extend the current therapeutic indication to include its use in initial combination therapy for PAH patients. PAH is characterized by constriction of the blood
Antimicrobial resistance seen in multidrug-resistant tuberculosis (MDR-TB) is one of the world’s most serious public health threats. MDR-TB is resistant to at least two of the four most
BTI-320 is a non-systemic chewable complex carbohydrate-based compound developed to reduce post-meal elevation of blood glucose. The trial’s primary endpoints are the mean change in Hemoglobin A1c (or
The new production facility will more than double the company’s existing manufacturing capacity in a facility design. The company offers clinical and commercial manufacturing services under cGMP for
Recombinant Nematode Anticoagulation Protein c2 (rNAPc2) has previously showed post-exposure efficacy in non-human primate models of Ebola hemorrhagic fever virus (HFV) and it was originally developed as a
Ono and Kyowa Hakko Kirin will be responsible for conducting the trial in Japan, which will focus on evaluating the safety, tolerability and anti-tumor activity of the combination
Celebrex is indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis as well as for the management of acute pain in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.